Table 4.
Symptoms after the first dose and second dose in patients with IBD (study group).
| Characteristic | First dose, N = 102a | Second dose, N = 102a | P b |
|---|---|---|---|
| Injection site | |||
| Pain | 38 (37%) | 32 (31%) | 0.3 |
| Redness | 3 (2.9%) | 4 (3.9%) | >0.9 |
| Swelling | 4 (3.9%) | 3 (2.9%) | >0.9 |
| Systemic AEs | |||
| Tiredness | 19 (19%) | 25 (24%) | >0.9 |
| Headache | 15 (15%) | 21 (20%) | >0.9 |
| Muscle pain | 11 (11%) | 16 (15%) | >0.9 |
| Chills | 4 (3.9%) | 9 (8.8%) | 0.2 |
| Fever | 13 (13%) | 20 (20%) | 0.2 |
| Nausea | 1 (1.0%) | 2 (2.0%) | >0.9 |
| Joint pain | 8 (7.8%) | 4 (3.9%) | 0.3 |
a
n (%).
b
McNemar's Chi-squared test with continuity correction; McNemar's Chi-squared test.